Literature DB >> 7599869

Genetic anticipation and abnormal gender ratio at birth in familial primary pulmonary hypertension.

J E Loyd1, M G Butler, T M Foroud, P M Conneally, J A Phillips, J H Newman.   

Abstract

The genetic basis of familial primary pulmonary hypertension (FPPH) is unknown, but the clinical and pathologic features are the same as in sporadically occurring primary pulmonary hypertension (PPH). Because few families with this disease have been reported, the mode of inheritance and genetic features have not been clearly established. We previously reported a tendency for decreasing age of onset in subsequent generations of affected families. The purpose of this study was to examine the pattern of inheritance in a large number of families in an attempt to find clues to pathogenesis. From 24 families we studied 429 members, 124 of whom were known to carry the gene for disease. We constructed cumulative mortality curves for each gender of the 99 affected individuals. We analyzed gender ratios of progeny of affected members and carriers and compared age at death of affected members by generation. More females (160) than males (122) were born to persons carrying the gene, p < 0.01, suggesting selective wastage of male fetuses or an abnormal primary sex ratio. Genetic anticipation was confirmed; the age at death was 45.6 +/- 14.5 versus 36.3 +/- 12.6 versus 24.2 +/- 11 standard deviation (SD) years in successive generations, p < 0.05. Five cases of male-to-male transmission were observed, excluding X-linkage. Age at death was the same for males and females. More females had the gene (84 females, 40 males) and more females with the gene developed disease (72 of 84 females [86%] versus 27 of 40 males [68%]). The disease has highly variable penetrance among families.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7599869      PMCID: PMC6067924          DOI: 10.1164/ajrccm.152.1.7599869

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  26 in total

1.  FAMILIAL PULMONARY HYPERTENSION.

Authors:  K L MELMON; E BRAUNWALD
Journal:  N Engl J Med       Date:  1963-10-10       Impact factor: 91.245

2.  Primary pulmonary hypertension. Review of clinical features and pathologic physiology with a report of pulmonary hemodynamics derived from repeated catheterization.

Authors:  J C SLEEPER; E S ORGAIN; H D McINTOSH
Journal:  Circulation       Date:  1962-12       Impact factor: 29.690

3.  Recent studies in primary pulmonary hypertension, including pharmacodynamic observations on pulmonary vascular resistance.

Authors:  D T DRESDALE; R J MICHTOM; M SCHULTZ
Journal:  Bull N Y Acad Med       Date:  1954-03

Review 4.  The occurrence of primary pulmonary hypertension in twins with a review of etiological considerations.

Authors:  S W Czarnecki; H M Rosenbaum; H L Wachtel
Journal:  Am Heart J       Date:  1968-02       Impact factor: 4.749

5.  Primary pulmonary hypertension occurring in twins.

Authors:  C M Porter; B J Creech; F T Billings
Journal:  Arch Intern Med       Date:  1967-08

6.  Familial occurrence of primary pulmonary hypertension.

Authors:  H S Kingdon; L S Cohen; W C Roberts; E Braunwald
Journal:  Arch Intern Med       Date:  1966-11

7.  Familial primary pulmonary hypertension: clinical patterns.

Authors:  J E Loyd; R K Primm; J H Newman
Journal:  Am Rev Respir Dis       Date:  1984-01

8.  Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox.

Authors:  Y H Fu; D P Kuhl; A Pizzuti; M Pieretti; J S Sutcliffe; S Richards; A J Verkerk; J J Holden; R G Fenwick; S T Warren
Journal:  Cell       Date:  1991-12-20       Impact factor: 41.582

9.  Sudden unexpected death from primary pulmonary hypertension.

Authors:  D L Brown; C V Wetli; J H Davis
Journal:  J Forensic Sci       Date:  1981-04       Impact factor: 1.832

10.  Primary pulmonary hypertension. A national prospective study.

Authors:  S Rich; D R Dantzker; S M Ayres; E H Bergofsky; B H Brundage; K M Detre; A P Fishman; R M Goldring; B M Groves; S K Koerner
Journal:  Ann Intern Med       Date:  1987-08       Impact factor: 25.391

View more
  51 in total

Review 1.  Primary pulmonary hypertension: the pressure rises for a gene.

Authors:  J R Thomson; R C Trembath
Journal:  J Clin Pathol       Date:  2000-12       Impact factor: 3.411

Review 2.  Primary pulmonary hypertension in childhood.

Authors:  S G Haworth
Journal:  Arch Dis Child       Date:  1998-11       Impact factor: 3.791

3.  Recommendations on the management of pulmonary hypertension in clinical practice.

Authors: 
Journal:  Heart       Date:  2001-09       Impact factor: 5.994

Review 4.  Therapeutic applications of sildenafil citrate in the management of paediatric pulmonary hypertension.

Authors:  Leah Leibovitch; Ilan Matok; Gideon Paret
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 5.  Pulmonary hypertension in women.

Authors:  Meredith E Pugh; Anna R Hemnes
Journal:  Expert Rev Cardiovasc Ther       Date:  2010-11

Review 6.  Pulmonary hypertension-"state of the art" management in 2012.

Authors:  Anita Saxena
Journal:  Indian Heart J       Date:  2012-03-26

Review 7.  Epidemiology of pulmonary arterial hypertension.

Authors:  Xin Jiang; Zhi-Cheng Jing
Journal:  Curr Hypertens Rep       Date:  2013-12       Impact factor: 5.369

8.  Pulmonary hypertension: diagnosis and management.

Authors:  Michael D McGoon; Garvan C Kane
Journal:  Mayo Clin Proc       Date:  2009-02       Impact factor: 7.616

9.  A novel BMPR2 mutation associated with pulmonary arterial hypertension in an octogenarian.

Authors:  Shilpa Johri; Gan H Dunnington; Cindy L Vnencak-Jones
Journal:  Lung       Date:  2010-05-23       Impact factor: 2.584

Review 10.  Genomics of pulmonary arterial hypertension: implications for therapy.

Authors:  Mark W Geraci; Todd M Bull; Rubin M Tuder
Journal:  Heart Fail Clin       Date:  2010-01       Impact factor: 3.179

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.